Arjuna Capital reduced its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 3.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 17,712 shares of the company’s stock after selling 572 shares during the period. Arjuna Capital’s holdings in Cardinal Health were worth $2,095,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Van ECK Associates Corp boosted its stake in shares of Cardinal Health by 4.9% during the 3rd quarter. Van ECK Associates Corp now owns 31,996 shares of the company’s stock worth $3,581,000 after acquiring an additional 1,507 shares during the period. Radnor Capital Management LLC lifted its holdings in Cardinal Health by 14.2% during the 3rd quarter. Radnor Capital Management LLC now owns 2,409 shares of the company’s stock valued at $266,000 after purchasing an additional 299 shares during the last quarter. Graypoint LLC boosted its position in Cardinal Health by 6.9% during the third quarter. Graypoint LLC now owns 2,380 shares of the company’s stock worth $263,000 after purchasing an additional 154 shares during the period. Hara Capital LLC bought a new position in Cardinal Health during the third quarter worth $31,000. Finally, Consolidated Planning Corp increased its holdings in shares of Cardinal Health by 16.4% in the third quarter. Consolidated Planning Corp now owns 6,374 shares of the company’s stock valued at $704,000 after purchasing an additional 897 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts recently commented on the stock. Morgan Stanley lifted their target price on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a report on Friday, January 31st. Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $132.00 to $145.00 in a research report on Monday, January 6th. Mizuho began coverage on Cardinal Health in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 target price on the stock. Jefferies Financial Group raised Cardinal Health from a “hold” rating to a “buy” rating and lifted their price target for the stock from $140.00 to $150.00 in a report on Wednesday, February 5th. Finally, JPMorgan Chase & Co. upped their price objective on Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus price target of $139.36.
Cardinal Health Stock Performance
Shares of NYSE CAH opened at $126.40 on Friday. The stock has a market capitalization of $30.53 billion, a P/E ratio of 23.58, a PEG ratio of 1.49 and a beta of 0.66. The stock’s fifty day moving average is $125.43 and its 200 day moving average is $118.63. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $132.84.
Cardinal Health (NYSE:CAH – Get Free Report) last released its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Equities research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.
Cardinal Health Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.60%. Cardinal Health’s dividend payout ratio is currently 37.69%.
Cardinal Health Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More
- Five stocks we like better than Cardinal Health
- Investing in the High PE Growth Stocks
- Is Myers Industries Poised for a Breakout?
- What Are Dividends? Buy the Best Dividend Stocks
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- The Risks of Owning Bonds
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.